Athira Pharma Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Due Diligence for Asset Managers
Analyze the public filings of asset managers
Dive into the EDGAR, IAPD, CAFR source data
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Athira Pharma Inc
TickerLONA
CIK #0001620463
CUSIP04746L203
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address4000 Mason Road, Suite 300 Box 352141, Seattle, WA 981952141
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Athira Pharma Inc 2020-06-12 89.0 M Exemption: 506(b) · Remaining: $1,936,670 · Duration: One year or less · Commission: $3,445,000 · Revenue: Decline to Disclose
M3 Biotechnology Inc 2015-11-20 14.1 M Exemption: 506(b) · Remaining: $2,885,000 · Duration: More than one year · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001620463] 10-K
[0001620463] 10-Q
[0001620463] 3
[0001620463] 4
[0001620463] 5
[0001620463] 8-K
[0001620463] D
[0001620463] SC 13D
[0001620463] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
ADAR1 Capital Management LLC Leonabio Inc [2026-05-15] 0.0
Acorn BioVentures LP Athira Pharma Inc [2025-12-23] 0.0
Baselake Partners LP Athira Pharma Inc [2025-11-14] 0.0
Oliveira Steven Michael Athira Pharma Inc [2025-04-16] 0.0
BML Investment Partners LP Athira Pharma Inc [2024-11-07] 5.8
Baker Bros Advisors LP Athira Pharma Inc [2024-02-14] 8.3
Kayne Richard A Athira Pharma Inc [2023-04-20] 5.3
BlackRock Inc Athira Pharma Inc [2022-02-04] 6.6
Franklin Resources Inc Athira Pharma Inc [2022-02-03] 5.6
Kawas LEEN Athira Pharma Inc [2021-02-16] 5.2
Perceptive Advisors LLC Athira Pharma Inc [2021-02-08] 0.8
Venrock Healthcare Capital Partners II LP Athira Pharma Inc [2020-11-16] 5.1
Viking Global Investors LP Athira Pharma Inc [2020-09-28] 6.9
RTW Investments LP Athira Pharma Inc [2020-09-28] 8.66
Form 3/4/5 Filer 2011 - 2026
LeonaBio Inc
Edelman Joseph
Kosacz Barbara
Silverman Peter B
Romano Kelly A
Panzara Michael A
Callori Fred
Pickering Grant
Holles Natalie C
Johnson James A
Church Kevin
Worthington Mark
Litton Mark James
San Martin Javier
Fluke John M Jr
Renninger Robert
Perceptive Advisors LLC
Perceptive Life Sciences Master Fund Ltd
Perceptive Xontogeny Venture Fund II LP
Gengos Andrew
Lenington Rachel
Moebius Hans
Mileson Glenna
Yamada Tadataka
Kawas LEEN
Wong Roderick
RTW Investments LP
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Church Kevin
Common Stock
2026-03-04 Sell 1,359 $5.37 7,298
Renninger Robert
Common Stock
2026-03-04 Sell 906 $5.37 4,865
Litton Mark James
Common Stock
2026-03-04 Sell 5,156 $5.37 27,688
San Martin Javier
Common Stock
2026-03-04 Sell 1,720 $5.37 9,236
Worthington Mark
Common Stock
2026-03-04 Sell 1,328 $5.37 7,131
Church Kevin
Restricted Stock Units · derivative
2026-03-03 Option exercise 5,856 $0.00
San Martin Javier
Restricted Stock Units · derivative
2026-03-03 Option exercise 7,418 $0.00
Church Kevin
Common Stock
2026-03-03 Option exercise 5,856 $0.00
Litton Mark James
Restricted Stock Units · derivative
2026-03-03 Option exercise 22,254 $0.00
Worthington Mark
Common Stock
2026-03-03 Option exercise 5,726 $0.00
San Martin Javier
Common Stock
2026-03-03 Option exercise 7,418 $0.00
Renninger Robert
Restricted Stock Units · derivative
2026-03-03 Option exercise 3,900 $0.00
Worthington Mark
Restricted Stock Units · derivative
2026-03-03 Option exercise 5,726 $0.00
Renninger Robert
Common Stock
2026-03-03 Option exercise 3,900 $0.00
Litton Mark James
Common Stock
2026-03-03 Option exercise 22,254 $0.00
San Martin Javier
Common Stock
2026-01-02 Sell 1,644 $6.88 11,311
Worthington Mark
Common Stock
2026-01-02 Sell 876 $6.88 6,027
Litton Mark James
Common Stock
2026-01-02 Sell 2,586 $6.88 17,792
Renninger Robert
Common Stock
2026-01-02 Sell 297 $6.88 2,043
Church Kevin
Common Stock
2026-01-02 Sell 876 $6.88 6,027
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 40 6,848,077
2025-12-31 42 6,205,300
2025-09-30 34 1,715,390
Form 13F Holdings
Firm Period DFND Voting Shares
Simplify Asset Management Inc [2026-06-30] SOLE 149,279 149,279
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com